Metastatic Ablation in Epidermal Growth Factor Receptor Mutated Oligometastatic Non-Small Cell Lung Cancer-Upfront or Outback After Systemic Tyrosine Kinase Inhibitors?
- Author(s)
- Siva, S; Solomon, BJ;
- Details
- Publication Year 2023-07-01,Volume 116,Issue #3,Page 481-482
- Journal Title
- International Journal of Radiation Oncology, Biology, Physics
- Publication Type
- Commentary
- Publisher
- Elsevier
- Keywords
- Humans; *Carcinoma, Non-Small-Cell Lung/genetics/therapy/pathology; *Lung Neoplasms/genetics/pathology; Tyrosine Protein Kinase Inhibitors; Gefitinib; Protein Kinase Inhibitors/therapeutic use/pharmacology; ErbB Receptors/genetics; Mutation
- Department(s)
- Radiation Oncology; Medical Oncology
- PubMed ID
- 37270244
- Publisher's Version
- https://doi.org/10.1016/j.ijrobp.2023.01.011
- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2023-10-24 04:47:23
Last Modified: 2024-07-16 04:29:33